Get started
Author

Matt Trotta

Observed institution: University of Pittsburgh
OpenAlex ID: A5050067916
Abstract A033: Inhibitors of GRK2-targeting-microRNAs: New therapeutic strategies for MALT1-dependent lymphomas
2026 · Jing Cheng, Mei Smyers, et al. · Blood Cancer Discovery
Abstract 2061: MicroRNAs targeting tumor suppressor GRK2: Novel potential therapeutic strategies for restraining MALT1-dependent DLBCL.
2026 · Jing Cheng, Mei Smyers, et al. · Cancer Research
MicroRNAS DOWNREGULATE TUMOR SUPPRESSOR GRK2 IN MALT1-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA
2025 · Jing Cheng, Mei Smyers, et al. · Leukemia Research
GRK2, an Inhibitor of MALT1-Dependent Oncogenic Signaling, Is Downregulated By microRNA in ABC-DLBCL
2023 · Jing Cheng, Mei Smyers, et al. · Blood
PDF
Abstract A18: GRK2, an inhibitor of MALT1-dependent oncogenic signaling, is downregulated by microRNA in ABC-DLBCL
2022 · Jing Cheng, Mei Smyers, et al. · Blood Cancer Discovery
Works count: 5
Citation count:
H-index:
I10-index:
Year
Topic
Type